Health & Wellbeing 2025
Brain Tumour Research

Closer to a Cure — 15 Years of Impact

Brain Tumour Research was founded in 2009 by families affected by brain tumours, with a mission to increase UK research investment and fund Centres of Excellence. Their 2025 impact report — marking 15 years — documents £46.4m contributed to the national research effort, five active Centres of Excellence, 260 research personnel supported, and major breakthroughs including an FDA-designated blood test for brain tumour detection and HIV drugs repurposed for schwannoma treatment.

View Report
Report snapshot
£23.2m awarded to research since 2009; £18.2m directly to Centres of Excellence; Centres leveraged additional £23.2m — total £46.4m contribution to national investment Key Metric 1
5 Centres of Excellence funded across UK; 39 PhD students supported; 260 research personnel supported; 167 publications underpinned Key Metric 2
130+ research projects supported through Funded Initiatives; 23 novel therapies reviewed by BTR-NTA; BRAIN UK tissue bank holds 210,000+ cases and has supplied 26,000+ samples to 110+ studies Key Metric 3
7 Views

📋About

Centres of Excellence at University of Plymouth, Imperial College London, Queen Mary University of London, Institute of Cancer Research (paediatric), Scottish Centre (Edinburgh/Glasgow); PRIME patient involvement programme, BTR-NTA therapeutics accelerator, BRAIN UK tissue bank Custom geography from upload: UK

📊Key Metrics

£23.2m awarded to research since 2009; £18.2m directly to Centres of Excellence; Centres leveraged additional £23.2m — total £46.4m contribution to national investment Key Metric 1
5 Centres of Excellence funded across UK; 39 PhD students supported; 260 research personnel supported; 167 publications underpinned Key Metric 2
130+ research projects supported through Funded Initiatives; 23 novel therapies reviewed by BTR-NTA; BRAIN UK tissue bank holds 210,000+ cases and has supplied 26,000+ samples to 110+ studies Key Metric 3

✅Key Outcomes

  • Blood test for high-grade brain tumours granted FDA Breakthrough Device Designation (2023); Barts Brain Tumour Centre grew from zero clinical trials in 2019 to running the most brain tumour clinical trials of any UK neuro-oncology centre in 2024
  • Scottish Brain Tumour Research Centre launched January 2025 with £2.4m over five years; PRIME patient involvement initiative helped secure over £28m in brain tumour trial funding
  • National annual spend on brain tumours increased from under £4m in 2009 to over £17m; 140 global research group collaborations across 19 countries; HIV anti-retroviral RETREAT trial launched June 2024 for schwannoma/NF2 patients

📍Geography

UK-Wide

Related reports

All Health & Wellbeing reports →
2025
The Christie Charity

Annual Report 2024/25

£20.8m raised in 2024/25 (up from £17.4m in 2023/24)
Key Metric 1
£9.6m raised from 176 legacy gifts; £14m committed to new Total Body PET-CT scanner
Key Metric 2
49,000 active supporters; 3,857 running participants (doubled in 3 years); 83p in every £1 goes directly to patients
Key Metric 3
MyChristie-MyHealth ePROMs system reduces clinician time on routine reviews by up to 23% and enables earlier symptom detection
Health & Wellbeing Wellbeing
View
2026
Momentum Children's Charity

Impact Report Year Ending April 2026

2,829 children, parents, siblings and grandparents supported; 506 families with a child in treatment
Key Metric 1
220 bereaved families supported; 424 individuals on 93 boat trips; 692 individuals in 165 cabin breaks
Key Metric 2
£71,935 unlocked in essential support; 1,320 social work hours; 188 creative therapy sessions and 271 counselling sessions delivered
Key Metric 3
Families show average 0.7 point improvement across five Mo's Outcomes after support begins; biggest gains in social participation and accessing emotional support
Health & Wellbeing Families
View